P Lafforgue Selected Research

Antibodies

2/2024

[High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Lafforgue Research Topics

Disease

2	Necrosis 01/2018 - 09/2015
2	Pain (Aches) 09/2015 - 01/2006
1	Systemic Scleroderma (Systemic Sclerosis) 02/2024
1	Osteoarthritis 09/2015
1	Infections 06/2008
1	Compression Fractures (Compression Fracture) 01/2006
1	Wounds and Injuries (Trauma) 10/2002
1	Proteinuria 07/2002
1	Amelogenesis Imperfecta 07/2001
1	Anodontia (Hypodontia) 07/2001
1	Uveitis 01/2000
1	Anterior Uveitis 01/2000

Drug/Important Bio-Agent (IBA)

2	Pamidronate (Aredia)FDA LinkGeneric 01/2006 - 01/2000
1	anticentromere antibodyIBA 02/2024
1	AntibodiesIBA 02/2024
1	AutoantibodiesIBA 02/2024
1	RNA Polymerase IIIIBA 02/2024
1	ElementsIBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 09/2015
1	Adalimumab (Humira)FDA Link 09/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2015
1	Prednisone (Sone)FDA LinkGeneric 06/2008
1	Carbon Fiber (Grafil)IBA 10/2002
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2002
1	CreatinineIBA 07/2002

Therapy/Procedure

1	Bandages (Bandage) 10/2002
1	Drug Therapy (Chemotherapy) 07/2001